{"schema_version":"1","generated_at":"2026-11-15T08:42:31.368Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ashwin-sama","json_url":"https://www.findmykol.com/kol/ashwin-sama/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ashwin-sama","name":"Ashwin Sama","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1710106422","openalex":"A5112261577"},"summary":"Ashwin Sama is an Oncology physician. OpenAlex indexes 59 publications with 620 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":59,"cited_by_count":620,"h_index":12,"latest_activity_year":2025,"source":"works"},"prescribing":{"data_year":2021,"areas_total":1,"areas_shown":1,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":100,"classes_total":1,"classes":[{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":100,"drugs":[{"name":"Creon","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2021,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence","year":2025,"journal":"Oncotarget","source_url":"https://doi.org/10.18632/oncotarget.28739","status":"verified"},{"title":"Abstract 2145: Genomic and transcriptomic analyses related to the clinical efficacy of first-line nivolumab in advanced hepatocellular carcinoma from the phase 3 CheckMate 459 trial","year":2022,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2022-2145","status":"verified"},{"title":"RWD110 Real World Outcomes in Patients with Advanced/Metastatic Solid Tumors Who Are Immuno-Oncology (IO) Naive and Received Second-Line Therapy: Analysis by Tumor Mutational Burden (TMB) Status","year":2022,"journal":"Value in Health","source_url":"https://doi.org/10.1016/j.jval.2022.09.2335","status":"verified"},{"title":"Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.269","status":"verified"},{"title":"A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.tps349","status":"verified"}],"source":"works"},"contact":{"address_1":"925 CHESTNUT ST","address_2":"SUITE 320A","city":"Philadelphia","state":"PA","zip":"191074216","phone":"215-955-8874","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1710106422","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-08-01","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021}},"methodology_url":"https://www.findmykol.com/about#methodology"}